Back

STRIP2 Stabilizes LCN2 to Suppress Ferroptosis and Drives Colorectal Cancer Malignancy

Ye, X.; Zhou, S.; Chen, X.; Hu, C.; Hu, H.; Ding, J.; Teng, W.

2026-05-19 cancer biology
10.64898/2026.05.16.725308 bioRxiv
Show abstract

Colorectal cancer (CRC) poses a severe global health threat with high incidence, mortality, and poor 5-year survival rates for advanced cases despite existing treatments. This study aims to explore the role of STRIP2 in CRC progression and its underlying mechanisms. Impact of STRIP2 on CRC in vitro was investigated via CRC cell proliferation, migration, invasion, and apoptosis. The in vivo impact was investigated via nude mice models. The role of STRIP2 in CRC was investigated via transcriptomic analysis, Western blot, Co-immunoprecipitation assays and ferroptosis validations. STRIP2 is overexpressed in CRC, driving malignant phenotypes in vitro and in vivo. Mechanically, STRIP2 stabilizes the IL17 downstream effector LCN2 by blocking its K48-linked ubiquitination and degradation, enhances anti-ferroptosis of CRC cells. Oe-STRIP2 suppresses ferroptosis, boosting proliferation and reducing oxidative stress; while si-STRIP2 induces the opposite effect. This study suggests STRIP2-mediated stabilization of LCN2 and enhances CRC cells ferroptosis resistance, thus promoting CRC cell survival and mediates malignant progression in CRC, which provides a novel link between STRIP2 and ferroptosis regulation in CRC. HighlightO_LISTRIP2 is overexpressed in CRC tissues and cells C_LIO_LISTRIP2 blocks LCN2 Ubiquitination and stabilizes LCN2 C_LIO_LISTRIP2 suppresses CRC ferroptosis C_LIO_LISTRIP2 drives CRC malignant phenotypes both in vitro & in vivo C_LI Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=113 SRC="FIGDIR/small/725308v1_ufig1.gif" ALT="Figure 1"> View larger version (52K): org.highwire.dtl.DTLVardef@1baf7baorg.highwire.dtl.DTLVardef@1de15d9org.highwire.dtl.DTLVardef@16c8078org.highwire.dtl.DTLVardef@667840_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 14 journals account for 50% of the predicted probability mass.

1
Cell Death Discovery
51 papers in training set
Top 0.1%
6.6%
2
Cell Death & Disease
126 papers in training set
Top 0.1%
6.6%
3
Advanced Science
249 papers in training set
Top 3%
5.0%
4
iScience
1063 papers in training set
Top 2%
5.0%
5
Cell Communication and Signaling
35 papers in training set
Top 0.1%
4.4%
6
Signal Transduction and Targeted Therapy
29 papers in training set
Top 0.2%
4.1%
7
Cell Reports
1338 papers in training set
Top 14%
3.7%
8
British Journal of Cancer
42 papers in training set
Top 0.5%
2.8%
9
eLife
5422 papers in training set
Top 31%
2.7%
10
International Journal of Molecular Sciences
453 papers in training set
Top 4%
2.4%
11
Computational and Structural Biotechnology Journal
216 papers in training set
Top 3%
2.2%
12
Redox Biology
64 papers in training set
Top 0.3%
2.1%
13
PLOS ONE
4510 papers in training set
Top 47%
2.1%
14
Neoplasia
22 papers in training set
Top 0.1%
1.9%
50% of probability mass above
15
Scientific Reports
3102 papers in training set
Top 52%
1.9%
16
Frontiers in Oncology
95 papers in training set
Top 2%
1.5%
17
Cells
232 papers in training set
Top 3%
1.4%
18
Nature Communications
4913 papers in training set
Top 55%
1.4%
19
Gastroenterology
40 papers in training set
Top 1%
1.3%
20
PeerJ
261 papers in training set
Top 9%
1.3%
21
International Journal of Biological Macromolecules
65 papers in training set
Top 2%
1.3%
22
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 6%
1.1%
23
Frontiers in Immunology
586 papers in training set
Top 6%
1.0%
24
Cell Death & Differentiation
48 papers in training set
Top 0.4%
1.0%
25
Biomedicines
66 papers in training set
Top 2%
0.9%
26
Oncogene
76 papers in training set
Top 2%
0.8%
27
Cancers
200 papers in training set
Top 4%
0.8%
28
Science China Life Sciences
26 papers in training set
Top 2%
0.8%
29
Aging
69 papers in training set
Top 3%
0.8%
30
Cellular and Molecular Life Sciences
84 papers in training set
Top 0.6%
0.8%